Highlights
IIA supported (ever)1 patentProfile claimed by owner
About
Molecular Testing Platform
Kanso diagnostics develop a molecular testing platform for diagnosis of bacterial and viral infections. The company's solution aims to change the contemporary diagnostics experience, and the platform facilitates the at-home medical revolution, ensuring accessibility and ease of use. Kanso's novel technology accurately detects multiple pathogens and genetic biomarkers from a single sample, minimizing diagnosis time-to-results from days to minutes. This proprietary technology offers PCR-grade accuracy and rapid home testing convenience, providing an end-to-end solution for diagnosing bacterial and viral infections, available anywhere and anytime.
Identity
| Name | Kanso Diagnostics |
|---|---|
| Slug | kanso-diagnostics |
| Type / kind | startup |
| Source _id | NAdktiBcpRZIbfwTpeU1QZl81uHyfRDVFuxJSF8FDEJsIAJZQAiqU1 |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Or Yehuda |
| HQ address | Or Yehuda, Israel |
Web & social
| Website | https://kansodx.com |
|---|---|
| https://www.linkedin.com/company/86834526 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesAssistive DevicesDiagnostics Devices
Technologies
BiologicalsMicroorganismsGenesMolecules
Target customers
Healthcare & Life SciencesHealthcarePatientsInsurance CompaniesProvidersMedical Devices IndustryMedical EquipmentLife SciencesBiotechnology
Business models
B2B2CB2B
Tags
molecular-biologydiagnosticsinfectious-diseasebiotechnology
Funding
| Total raised | $1.5M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}